Download PDF
Indian Journal of Neurotrauma 2009; 06(01): 49-52
DOI: 10.1016/S0973-0508(09)80026-9
Original article
Thieme Medical and Scientific Publishers Private Ltd.

Role of citicoline in the management of mild head injury

Aniruddha TJ
,
Shibu Pillai
,
B Indira Devi
,
S Sampath
,
BA Chandramouli
Subject Editor:
Further Information

Publication History

Publication Date:
05 April 2017 (online)

  PDF Download  Permissions and Reprints

Abstract

Mild head injuries can cause functional disabilities resulting in economic loss. Post concussion syndrome is seen in 15–45% of these patients. Cytidine-5′-diphosphocholine (citicoline) is known to improve cognitive dysfunction. This study was undertaken to evaluate the effect of citicoline on the number of working days lost and on post concussion symptoms following mild head injury in adults, in a randomized, prospective, single blind study. Following informed consent, adults with mild head injury (Glasgow coma score of 13–15, <24 hours) were randomized, using a computer generated randomization table, to receive either citicoline (1 gram/day) or placebo for one month. The parameters evaluated at one month were number of working days lost, Glasgow outcome score, presence of post concussion symptoms and the Rivermead head injury follow up questionnaire (RHFQ) scores. The groups were compared using Pearson chi-square test and fisher's exact test. The groups were well matched with respect to age, gender, GCS and mode of injury. There was no difference in the number of working days lost between the groups (P=0.061), Glasgow outcome score (P=0.281), Rivermead head injury follow up questionnaire scores (P=0.667) and the post concussion symptoms (P=0.3) between the groups. Compared to placebo, one gram/ day of citicoline for one month in patients with mild head injury did not reduce either the number of working days lost, or the post concussion symptoms. There was no difference in the quality of life between patients taking citicoline and placebo.

Keywords

mild head injury - citicoline - post concussion symptoms
 

  • References

  • 1 Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy C W, Penny KI. Disability in young people and adults one year after head injury: prospective cohort study. BMJ 320 7250 2000; 1631-1635
    CrossrefPubMedGoogle Scholar
  • 2 Gururaj G. Epidemiology of traumatic brain injuries: Indian scenario. Neurol Res 24 2002; 24-28
    CrossrefPubMedGoogle Scholar
  • 3 Elgmark AE, Emanuelson I, Bjorklund R, Stalhammar DA. Mild traumatic brain injuries: the impact of early intervention on late sequelae. A randomised controlled trial. Acta Neurochir(Wien) 149 2007; 151-159
    CrossrefPubMedGoogle Scholar
  • 4 Whittaker R, Kemp S, House A. Illness perceptions and outcome in mild head injury: a longitudinal study. J Neurol Neurosurg Psychiat 78 2007; 644-646
    CrossrefPubMedGoogle Scholar
  • 5 McAllister Thomas W. Mild traumatic brain injury and the postconcussive syndrome. In, Jonathan M Silver, Stuart C Yudofsky, Robert E Hales (eds). Neuropsychiatry of traumatic brain injury. American Psychiatric Publication Inc 1994; 357-392
    PubMedGoogle Scholar
  • 6 Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: Observations on the use of Galsgow Outcome Scale. J Neurol Neurosurg Psychiat 44 1981; 285-293
    CrossrefPubMedGoogle Scholar
  • 7 Tennant Jr FS, Wild J. Naltrexone treatment for postconcussional syndrome. Am J Psychiat 144 1987; 813-814
    CrossrefPubMedGoogle Scholar
  • 8 Gualtieri C T, Evans RW. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj 02 1988; 273-290
    CrossrefPubMedGoogle Scholar
  • 9 Jakola AS, Muller K, Larsen M, Waterloo K, Romner B, Ingebrigsten T. Five-year outcome after mild injury: a prospective controlled study. Acta Neurol Scand 115 2007; 398-402
    CrossrefPubMedGoogle Scholar
  • 10 Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol 12 1989; 258-270
    CrossrefPubMedGoogle Scholar
  • 11 Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review. Clin Pharmacol 28B(suppl) 2006; 1-56
    PubMedGoogle Scholar
  • 12 Levin HS. Treatment of postconcussional symptoms with CDP-Choline. J Neurol Sci 103 suppl 1991; S39-S42
    CrossrefPubMedGoogle Scholar
  • 13 Teasdale G, Jennett B. A practical scale. Lancet 02 7872 1974; 81-84
    PubMedGoogle Scholar
  • 14 Crawford S, Wenden FJ, wade D T. The rivermead head injury follow-up questionnaire: a study of a new rating scale and other measusres to evaluate outcome after head injury. J Neurol Neurosurg Psychiat 60 1996; 510-514
    CrossrefPubMedGoogle Scholar